Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.
PrivateLast Round
Series B
Extension
Mar 27, 2025
Total Funding Raised
$27.58M
Company Overview
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series B round in June 2024.
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. is a biotechnology company that develops and manufactures automated, closed, and digital cell processing systems for cell and gene therapy applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Comparables
Compare Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Limula | 88% | |
| Sino-Biocan (Shanghai) Biotech Ltd | 86% | |
| Ori Biotech | 83% |
For institutional investors. Book with your work email.
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Mar 27, 2025 | ||||
| Series B | Jun 13, 2024 | ||||
| Series A | Oct 14, 2021 | ||||
| VC Round | Sep 1, 2020 | ||||
| Angel | Apr 1, 2020 |
For institutional investors. Book with your work email.
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing Chang Development | Series B, VC Round |
| Bencao Capital | Series B |
| Delian Capital | Series A |
| Changzhou Hi-tech Group Co., Ltd. | Series B Extension |
| MPC | Series A |
| Tsinghua Innovation Ventures | Series B, Angel |
| 启迪之星创投 | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
Grew 21% QoQ from 14 to 17 employees.
- Apr 22, 2026
Grew 31% QoQ, from 13 to 17 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardSep 7, 2026
Frost & Sullivan presents the "Global CGT Industry Enabling Technology Innovation Leadership Award" to CellBri Bio Innovation Technology LTD. in China on Aug 4th '26, based on research and evaluation of companies in the global CGT industry enabling sector.
- receives_awardSep 7, 2026
Frost & Sullivan’s independent judging panel decides to award the "2026 GLOBAL CGT INDUSTRY ENABLING TECHNOLOGY INNOVATION LEADERSHIP AWARD" to CellBri Bio Innovation Technology LTD. for technological innovation, commercial success, and customer value.
For institutional investors. Book with your work email.
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. a public or private company?
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. is a private company.
What is the current stock price of Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.?
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. worth (valuation)?
Valuation information for Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. is not publicly available.
Can I buy Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. stock?
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.'s last funding round?
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.'s most recent funding round was Series B Extension on March 27, 2025.
Who are the main investors in Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.?
Key investors in Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. include Bencao Capital, MPC, Tengye Ventures.
Will Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen Cellbri Bio-Innovation Technology Co., Ltd..
How can I track Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shenzhen Cellbri Bio-Innovation Technology Co., Ltd.'s shares on secondary markets.